On-Demand:
Incorporating Digital Measures & Endpoints Into Clinical Trials:
Key Regulatory Considerations
Tuesday, April 16th, 2024
10am ET | 3pm GMT | 7am PT
Webinar
Leverage the advantages of digital endpoints
As technology advances and clinical innovations such as digital endpoints and biomarkers become more prevalent in the life sciences industry, the regulatory considerations surrounding them grow in complexity. Learn how to navigate this evolving space, with insights from this free webinar.
Experts from Biofourmis will discuss:
- Traditional versus digital measures in clinical research and their key differences.
- The current regulatory framework for digital endpoints, including regional disparities.
- Regulatory considerations for data integrity and security, validation and reliability, and patient safety and privacy.
- How to Integrate digital endpoints into trial protocols.
- Emerging and regulatory trends and future regulatory direction.
Meet the Speakers
Seth Kuzdzal
SVP, Quality Assurance and Regulatory Affairs, Biofourmis
Tarik Yardibi
Director, Digital Health Sciences, Takeda
Doug Burgener
Senior Director, Marketing, Biofourmis
Register now to watch on-demand!
By completing this form you agree Biofourmis and Citeline may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy and Citeline privacy policy.
Inspire. Connect. Innovate.
